A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1997
10/02/1997	CA2249417A1 Manipulation of mitotically active cells of the hippocampal region of the brain
10/02/1997	CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997	CA2249254A1 Epidermal differentiation factor
10/02/1997	CA2249212A1 Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide
10/02/1997	CA2248675A1 Cyclic nucleotide phosphodiesterase
10/02/1997	CA2248318A1 Growth factor htter36
10/01/1997	EP0798002A1 Inhibition of vascular stenosis
10/01/1997	EP0798001A2 Collagen containing preparations for strengthening bone
10/01/1997	EP0798000A2 Treating disorders by application of insulin-like growth factors and analogs
10/01/1997	EP0797999A2 Formulations of obesity protein
10/01/1997	EP0797998A1 Endothelial cell protective
10/01/1997	EP0797997A2 Use of bradykinin antagonists for the preparation of medicaments
10/01/1997	EP0797993A1 Compostions comprising l-carnitine or derivatives thereof and antioxidants
10/01/1997	EP0797988A2 Anti-angiogenic compositions and methods of use
10/01/1997	EP0797678A2 Hybrid adenovirus-aav virus and method of use thereof
10/01/1997	EP0797676A2 Recombinant adenoviral vector and methods of use
10/01/1997	EP0797666A2 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase
10/01/1997	EP0797664A1 Human interleukin-11 receptor
10/01/1997	EP0797663A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage
10/01/1997	EP0797593A2 Improved cyclic crf antagonists
10/01/1997	EP0797592A1 Human stanniocalcin-alpha
10/01/1997	EP0797591A1 A novel chemokine expressed in inflamed adenoid, its production and uses
10/01/1997	EP0797590A1 Neurotrophic peptides of activity dependent neurotrophic factor
10/01/1997	EP0797588A1 BETA 3? INTEGRIN SUBUNIT SPECIFIC POLYPEPTIDES, cDNAs WHICH ENCODE THESE POLYPEPTIDES AND METHODS OF PRODUCING THESE POLYPEPTIDES
10/01/1997	EP0797587A1 Recombinant antigen for diagnosing rheumatoid arthritis
10/01/1997	EP0797586A1 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI
10/01/1997	EP0797584A1 Cooperative combinations of ligands contained within a matrix
10/01/1997	EP0797583A1 Tachykinin antagonists
10/01/1997	EP0797581A1 Novel protein tyrosine kinase, jak3
10/01/1997	EP0797455A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c
10/01/1997	EP0797454A1 Improved adenoviral vectors and producer cells
10/01/1997	EP0797450A1 In vitro t-lymphopoiesis system
10/01/1997	EP0797449A1 Method of treating hypertension using animal stomach mucosa extract and endogenous protease-inhibitor peptides
10/01/1997	EP0797448A2 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative
10/01/1997	EP0797447A1 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
10/01/1997	EP0797446A1 Cd40 associated proteins
10/01/1997	EP0797431A1 Aerosol formulations of peptides and proteins
10/01/1997	EP0722331A4 Method for producing a highly enriched population of hematopoietic stem cells
10/01/1997	EP0648264A4 Bandage for continuous application of biologicals.
10/01/1997	EP0538443B1 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
10/01/1997	CN1161058A Intracellular isoform of the interleukin-1 receptor antagonist
10/01/1997	CN1161043A Peptide, bronchodilator and blood flow ameliorant
10/01/1997	CN1161001A Lipid metabolism ameliorant
10/01/1997	CN1160721A Fibrillating cell growth factor-2 analogue and its production method and use
10/01/1997	CN1160584A Sustained release formulation of animal growth hormone and process for preparation thereof
10/01/1997	CN1160583A 口疮散 San aphthous
10/01/1997	CN1160582A External-use composite containing cell growth factor
10/01/1997	CN1036010C Preparation and application of memory enhancing peptide (MEP)
10/01/1997	CN1036006C Antibiotic compound carbapenem
10/01/1997	CA2201185A1 Anti-fas recombinant antibodies and dna therefor
09/1997
09/30/1997	US5672695 Modified ribozymes
09/30/1997	US5672692 Purification of human myelomonocyte interferon gamma with an immobilized antibody
09/30/1997	US5672689 Non-cleavable GP160 glycoproteins of HIV
09/30/1997	US5672687 Medical diagnosis; bone marrow transplants
09/30/1997	US5672686 Genetic engineering
09/30/1997	US5672683 Nerve growth factor or ciliary neurotrophic factor bound at its amino end to the carboxyl end of a transferrin, for delivery across blood brain barrier
09/30/1997	US5672682 Conotoxin peptide PVIIA
09/30/1997	US5672681 Conformationally restricted mimetics of gamma turns and peptides containing the same
09/30/1997	US5672659 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
09/30/1997	US5672622 Phosphodiesterase inhibitor; rolipram
09/30/1997	US5672607 Antiviral naphthoquinone compounds, compositions and uses thereof
09/30/1997	US5672599 Compounds containing a fused bicycle ring
09/30/1997	US5672598 Matrix metalloprotease inhibitors
09/30/1997	US5672596 Animal growth controllers
09/30/1997	US5672586 Herpes ribonucleotide reductase inhibitors
09/30/1997	US5672585 Method and composition for treating thrombosis
09/30/1997	US5672584 Modified with end groups
09/30/1997	US5672582 Anticoagulants; 4-substituted cyclohexylamine derivatives
09/30/1997	US5672581 Drug delivery; aerosol, programmed, portable, disposable
09/30/1997	US5672511 Base-modified enzymatic nucleic acid
09/30/1997	US5672508 Polypeptide comprising cyclin dependent kinase binding motifs from two or more proteins
09/30/1997	US5672500 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
09/30/1997	US5672493 Transduction of human fibroblast cells with snyder-theilen:fesv, harvesting the floating transduced cells and replating; gene and somatic cell therapy; anticarcinogenic and -tumor agents
09/30/1997	US5672486 Protein polyligands joined to a stable protein core
09/30/1997	US5672479 Contacting sample with a solid phase matrix, where pur-protein or fragemnts are immobilized to the matrix to permit binding, removing unbound material, detecting the presence of bound material to the matrix
09/30/1997	US5672473 Methods of identifying compounds useful for treating autoimmune diseases
09/30/1997	US5672366 Method of improving efficiency in ruminants
09/30/1997	US5672361 Laminin 5 for growth of pancreatic islet cells
09/30/1997	US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles
09/30/1997	US5672347 Administering in therapeutically effective dosage to suppress transplantation immunity
09/30/1997	US5672343 N- 3 deletion mutants of the long form of CSF-1
09/30/1997	US5672336 Process of preparing microparticulate collagen, collagen-based products thereby and method of applying same
09/30/1997	US5671848 Tagged antibodies capable of recognizing the non-variable region of the anti-heat shock protein 65 antibody to be detected
09/27/1997	CA2200040A1 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders
09/25/1997	WO1997035199A1 Azatide peptidomimetics
09/25/1997	WO1997035193A1 Cryptic peptides and method for their identification
09/25/1997	WO1997035028A1 Cytostatin iii
09/25/1997	WO1997035027A1 Chemokine alpha 3
09/25/1997	WO1997035024A1 Enzyme combinations for destroying proliferative cells
09/25/1997	WO1997035021A2 Prostate specific antigen oligo-epitope peptide
09/25/1997	WO1997035020A1 Mch4 AND Mch5, APOPTOTIC PROTEASE, NUCLEIC ACIDS ENCODING AND METHODS OF USE
09/25/1997	WO1997035019A1 Protein tyrosine phosphatases of hematopoietic cells
09/25/1997	WO1997035018A1 Growth factor inducible serine/threonine phosphatase fin13
09/25/1997	WO1997035015A2 Tyrosine-phosphatase-related protein
09/25/1997	WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a)
09/25/1997	WO1997035012A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy
09/25/1997	WO1997035010A1 Chemokine alpha 2
09/25/1997	WO1997035009A1 Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
09/25/1997	WO1997035007A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use
09/25/1997	WO1997035006A1 Human cell death-associated protein

1 ... 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 ... 3163